Thread: Is China trying to poison Americans and their pets?

Is China trying to poison Americans and their pets?

U.S. market flooded with foods unfit for humans, tainted with carcinogens, pesticides, bacteria, drugs
Posted: May 27, 2007
1:00 a.m. Eastern


© 2007 WorldNetDaily.com

WASHINGTON – While Americans are still recovering from a scandal over poison pet foods imported from China, FDA inspectors report tainted food imports intended for American humans are being rejected with increasing frequency because they are filthy, are contaminated with pesticides and tainted with carcinogens, bacteria and banned drugs.

Last month, like most months, China topped the list of countries whose products were refused by the FDA – and that list includes many countries, including Mexico and Canada, who export far more food products to the U.S. than China.

Some 257 refusals of Chinese products were recorded in April. By comparison, only 140 were from Mexico and only 23 from Canada.

Refused by the FDA in April because they were "filthy":

* salted bean curd cubes in brine with chili and sesame oil
* dried apple
* dried peach
* dried pear
* dried round bean curd
* dried mushroom
* olives
* frozen bay scallops
* frozen Pacific cod
* sardines
* frozen seafood mix
* fermented bean curd

Among the foods rejected because they were contaminated with pesticides:

* frozen eel
* ginseng
* frozen red raspberry crumble
* mushrooms

Frozen catfish was stopped because it was laced with banned antibiotics. Scallops and sardines were turned away because they were coated with putrefying bacteria.

Toothbrushes were rejected last month because they were improperly labeled. And last week the FDA found Chinese toothpaste contaminated with a chemical used in antifreeze – the same chemical that killed people in Panama last year when it turned up in cough syrup.

The FDA is also on the lookout for vegetable proteins contaminated with melamine – the chemical that killed American cats and dogs when it was imported from China in pet food.

In the past year, the FDA rejected more than twice as many food shipments from China as from all other countries combined.

Most of the time, the reason listed is simply "filthy," the official term used when inspectors smell decomposition or gross contamination of food.

Officials say FDA inspectors examine only a tiny percentage of the food imported from foreign countries – about 1 percent -- meaning most of the contaminated products make it inside the country and to the shelves of retailers.

In the age of globalization, food imports in America are big business and getting bigger. In 2006, they represented $64 billion – a 33 percent increase over 2003. No country is increasing its food exports faster than China – about 20 percent in the last year alone.

China has become America's leading supplier of apple juice used as a food sweetener, garlic and garlic powder, sausage casings and cocoa butter.

China has also attempted to export hundreds of thousands of pounds of chickens and poultry products to the U.S., even though it is not yet certified to do so. Chinese exporters disguise the meat by labeling crates "dried lily flower" or "prune slices" or "vegetables."

Despite the deliberate deception, the U.S. government is about to certify the Chinese to export poultry legally.

http://wnd.com/news/article.asp?ARTICLE_ID=55892

Do not forget they now control Vitamin C

Originally Posted by redbadger

Do not forget they now control Vitamin C

They control Vitamin C ? That's a new one to me. Source?

W

It was reported on CNN ...approx..date about April 22 I remember since I was watching this in ICU while I stayed with my mother...I will search for it....and post info

http://www.in-pharmatechnologist.com/ne ... anti-trust

China's vitamin C makers ready for anti-trust battle




Get the latest Market Reports on
vitamin
china
anti-trust

Related News

DSM to close vitamin C plant in US
Chinese vitamin C maker in antitrust complaints
DSM gains full control of vitamin joint venture in China
Lower vitamin prices put pressure on BASF fine chemicals result
Vitamin C makers look for new edge


Related Product Information
Ingredients, excipients and raw materials






Related Product Newsletters
Ingredients, excipients and raw materials

News Archives

All news for May 2007
All news for April 2007


07/06/2005 - Chinese vitamin C manufacturers are preparing their defence to an anti-trust case filed by two American firms that allege price-fixing and control of the market since 2001, writes Dominique Patton.

The case is the first anti-trust case brought in the US against Chinese exporters, according to the People's Daily newspaper.
Wellcome Pharmaceutical Co received a summons from a US court last Wednesday, and has hired lawyers to deal with the case, according to a statement on its website.

Other companies involved were previously also busy preparing for the case although they had not been officially informed, said a report in the China Daily.

"Group leaders have negotiated how to deal with it as soon as they got the information," an anonymous official at Shijiazhuang Pharmaceutical Group in North China's Hebei Province told the paper. The group, its Hong Kong-listed company and a subsidiary were all sued.

Feed additive maker Animal Science Products and Ranis Company filed petitions against six Chinese vitamin C producers at the Supreme Court of California in late February.

They claim that vitamin C customers in the US paid more for vitamin C as a result of the alleged cartel.
Chinese manufacturers argued that their average export price of vitamin C to the United States was $4.57 per kg while the global average was $4.63.

Their prices were still lower than those of other major manufacturers, despite increases last year owing to higher energy and transport costs.

China makes 60 per cent of the world's vitamin C supply, with the four leading Chinese producers making 60,000 tons. About 80 per cent of this is exported.

WOW, I didn't know that either



--------------------------------------------------------------------------------

TRAVELING BULLETIN BOARD

To everybody out there hanging in the backround yes you!! we invite you to...
let your voices be heard, Its time to get involved, calls, faxes, and e-mails, post at the links below to let everyone know what you are hearing, it helps our leaders to make decisions on what steps to take next. Lets all let congress know what real Americans Want!!

Instructions here to help you !! "MEMORIAL WEEK CRACKDOWN"
post results at either link
http://www.alipac.us/modules.php?name=F ... sc&start=0
LETS RALLY TO "MEMORIAL WEEK OPERATION BRING IT HOME"
http://www.alipac.us/modules.php?name=F ... ic&t=63301

If anyone can't find information for contacting senators or not sure what to do, just ask, we have lots of nice people to help you

HINT: EASY WAY TO HELP OUT.....When you post on another site with good non-racist patriotic Americans leave behind a Momentous message, the link to ALIPAC ( http://www.alipac.us/index.php ).
Any donations to help keep ALIPAC afloat will be much appreciated

http://www.nutraingredients.com/news/ng ... -vitamin-c

DSM makes last stand against Chinese vitamin C

By Dominique Patton



Get the latest Market Reports on
DSM
vitamin C

Related News

DSM opens R&D centre in China
Lysine, vitamin prices wipe out profits at BASF fine chemicals
DSM to close vitamin C plant in US
DSM gains full control of vitamin joint venture in China
DSM cuts jobs at vitamin C plant
Vitamin C makers look for new edge


Related Product Information
Vitamins & premixes




Related Product Newsletters
Vitamins & premixes

News Archives

All news for May 2007
All news for April 2007


20/10/2005 - China's dominance of the vitamin C market was confirmed last week as DSM halted all production of the bulk vitamin in the US, making its Dalry plant in Scotland the only remaining major plant outside of Asia.
Four Chinese producers now supply the majority of the global demand for this vitamin, selling at prices well below the numbers that are feasible for DSM and the other remaining European vitamin maker, BASF.
But as BASF evaluates the future of its small Denmark plant, DSM says it will remain a significant player in vitamin C for the mid-term despite a smaller capacity.

The company will tap into growing demand for product traceability, quality guarantees, and fears of delivery insecurity. It will also push its expertise in formulation.

"If you look at the market on a surface level, there is lots of capacity available. But there is an undercapacity in a specific type of product," Bob Hartmayer, chief operating officer at the firm's Nutritional Products unit, told NutraIngredients.com.

"There are some markets that have basic needs in terms of performance that can be met by all producers. But there are a lot of segments that require more."

For example, if a customer is looking for a new form for a product they're tweaking, they know they can get help from DSM, he says.

Other companies looking to add a GMO-free label on products need guaranteed traceability, while companies concerned about brand equity will require certain levels of reassurance from their supplier.

"GM is a choice issue that not everyone wants, and we're not pushing it, but if a customer wants that now, we can offer secure traceability," claims Hartmayer.

Mauricio Adade, head of global marketing for the group, adds that western producers are the only ones that can supply GMP product for Europe's OTC market.

DSM has for some time charged higher prices for vitamin C for long-term contracts with its key accounts, based on advantages in terms of services and reliable supply.

But these advantages have not been enough to save the Belvidere, US plant from Chinese price pressure. And DSM's reduced output could widen the price gap between Chinese and European supply, enhancing further the differentation in the market.

The Belvidere plant accounted for half of DSM' overall production capacity for vitamin C. Some of the output there will be made up at Dalry, where recent investments have increased capacity by 30-40 per cent.

"But that alone will not make up the capacity lost in the US," said Hartmayer.

The firm will buy in some additional material and is also in ongoing talks with its Chinese partner NCPC although the two companies are not yet working together, according to Hartmayer.

He said output will not be 'significantly' smaller but declined to specify numbers. The Dalry plant has been producing about 22 tons annually.

Adade says there are no plans yet to increase prices "but we will evaluate it depending on how much demand goes up".

Whether DSM can sustain this differentiated vitamin C market remains to be seen. Customers burned by Chinese suppliers in the past may be nervous of the shift in globaly supply to the east, but consolidation among the Chinese producers and more stable prices in recent months does nothing to suggest that fluctuating supply will cause the same problems in the near future.

DSM is preparing for continued price pressure however, working on a new one-step fermentation process that would cut costs. The vitamin is currently produced through fermentation followed by a chemical conversion step.

It has not yet been tested on an industrial scale but in the lab "it looks like more than just a paper exercise," according to Hartmayer.

Adado expects to have commercial material from it in three to five years but the next two will prove crucial.

There are also changes at Dalry designed to allow for increased raw material flexibility to limit the impact from price rises on fermentation crops.

But as with most industries these days, DSM cannot rule out the possibility of moving all production to China.

"Never say never to anything. But we have made a commitment to Dalry in the short-term," said Hartmayer.

Along the same lines, here is the link for the list of FDA refusals. No pun intended, but this makes me ill.

http://www.fda.gov/ora/oasis/ora_oasis_ref.html

Holy bat turds.....

Originally Posted by redbadger

Holy bat turds.....

Yeah, I'm sure there are some of those in our imported food too.